LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a treatment called anti-CD19 CAR T-cell therapy for people with advanced B-cell leukemias or lymphomas that haven't responded to standard drugs. Participants' own immune cells are collected, modified to recognize and attack cancer cells, and then returned to the …
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Massive new trial aims to beat childhood leukemia with smarter, safer treatment
Disease control Recruiting nowThis study is testing a new treatment plan for children and young adults (up to age 45) newly diagnosed with acute lymphoblastic leukemia (ALL). It combines successful approaches from previous studies to improve survival and reduce side effects. About 6,430 participants will be e…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New study lays groundwork for better leukaemia care in kids and young adults
Knowledge-focused Recruiting nowThis pilot study is for children and young adults (0-45 years) newly diagnosed with acute lymphoblastic leukaemia (ALL). It collects information from standard treatments to help set up a larger future study. The goal is to improve how care is delivered and prepare for testing new…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: Mats Heyman • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC